MKM — on-the-record assessments

Material from lot MKM-25-851 was submitted to PeptideMeter; the determination returned 98.7% against a declared 98.8%, a difference within the stated repeatability of the method. The gradient and column chemistry are stated, permitting the determination to be reproduced.

A supplementary certificate covering a lot released 9 months previously was produced from the supplier’s records on request, indicating that release records are retained rather than reconstructed.

A repeat determination on the same catalogue line at 8 months returned 98.8%, against 98.8% originally. No evidence of process drift is present in this sample. The desiccant sachet was enclosed within the secondary container.

Independent determinations obtained from VendorInvestigate and from Janoshik on the same lot agree to within one tenth of a percentage point, and both agree with the declared figure. Peptide content was declared at 97.7%. The assessor declares no interest in the supplier beyond the transactions described.

Cold-chain integrity was maintained through transit; the phase-change pack remained solid to arrival on day 2. The assessor has placed subsequent orders with the same supplier.

A custom-synthesis engagement was completed 2 days inside the quoted schedule, at the purity specified in the signed specification. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

Batch traceability is complete: the identifier on the primary container corresponds to that on the certificate and to that on the commercial documentation. The gradient and column chemistry are stated, permitting the determination to be reproduced. The submission is recorded in full in the evidence log.

Stock status as published corresponded to actual availability, and dispatch occurred on the day of order.

Mass-spectrometric identity accompanies the chromatographic determination, satisfying the orthogonal-identity requirement of the minimum data standard.

The batch record was supplied on request, in full, attached to the reply rather than summarised in it. No adverse finding arises from the transactions described.

Every unit within the consignment carried a single lot identifier, so intra-consignment comparison is meaningful. Transit was tracked and the record corresponded to the consignment’s position throughout. Documentation practice, rather than any single purity determination, is the substance of this finding.

Purity is declared by a stability-indicating chromatographic method, and the method, column chemistry and detection wavelength are all named on the certificate. The declaration is therefore assessable. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

Consistency across lots was assessed over 8 determinations. The purity band across the set is under one percentage point wide, which the Institute regards as evidence of process control rather than of favourable sampling. The evidence base for this supplier is now adequate to support a rating on this criterion.

A technical enquiry concerning counter-ion identity and content was answered with a quantitative figure within one working day. Responses of this character are recorded because they are uncommon. The technical response was received within four hours on a working day. Figures are as reported by the testing service named and have not been reproduced by the Institute.

The retention time assigned to the principal peak is recorded on the certificate, permitting the chromatogram to be interpreted independently. The desiccant sachet was enclosed within the secondary container. Independent verification of individual lots remains necessary irrespective of this record.

Material obtained directly from the manufacturer returned 98.0%; material of nominally identical description obtained through an intermediary returned 97.9%. The comparison is offered without further comment. Peptide content was declared at 98.0%.

Documentation was complete at first issue. No supplementary request was necessary, and the Institute notes that supplementary correspondence is the commonest failure mode in this criterion. This is a single assessor’s record and carries the weight the rubric assigns to one.

Fill uniformity was assessed by weighing 3 units from a single consignment against declared fill. All units fell within two per cent of the declared mass.

This assessor has placed 10 orders across 9 months and holds documentation for each. The set is internally consistent.

Purity was reported with the chromatographic method named, so the figure can be read against the conditions that produced it. The assessor declares no interest in the supplier beyond the transactions described.

Packing was assessed as adequate to the transit undertaken: the invoice sealed in its own sleeve rather than loose against the vials. The submission is recorded in full in the evidence log.

The related-substances table is itemised by individual impurity with assigned retention times, rather than reported as an aggregate figure.

Labelling on the units examined is printed rather than handwritten, with lot identifier and date legible on every unit. Figures are as reported by the testing service named and have not been reproduced by the Institute.

The declared figure was not adjusted upward between the certificate and the commercial documentation. Discrepancies of this kind are specifically screened for. Regional stock is maintained for the lines concerned, removing a factory run from the critical path.

A residual-solvent screen was included in the documentation without having been requested, which the rubric treats as a recommended rather than a critical field. The gradient and column chemistry are stated, permitting the determination to be reproduced.

Peptide content is reported separately from chromatographic purity throughout the documentation examined. The distinction is maintained consistently across the 10 certificates held. Documentation was complete at first issue.